Literature DB >> 21654841

An intracytoplasmic IL-10 receptor variant permits rapid reduction in STAT3 activation.

M Finsterbusch1, V Khare, C Campregher, R Evstatiev, C Gasche.   

Abstract

Within the interleukin-10 receptor 1 (IL10R1) gene, two common variants are associated with certain diseases: single-nucleotide polymorphism 3 (SNP3), a serine-138 to glycine mutation is in linkage disequilibrium with SNP4, a glycine-330 to arginine mutation, both of which are considered loss-of-function alleles. However, the molecular consequence of G330R is unknown. We investigated possible roles of G330R on the dynamics of IL10R1 surface expression and signal transducer and activator of transduction (STAT) phosphorylation. HeLa cells expressing the respective IL10R1 haplotype were stimulated with IL-10. Significant reduction of IL10R1 surface expression was observed after ligand binding. Receptor expression remained low on continuous incubation with IL-10. In contrast, when treated with an IL-10 pulse, IL10R1 surface expression returned to its resting state within 3-9 h irrespective of the haplotype. STAT3 was rapidly phosphorylated both in cells with wild-type (WT) or variant IL10R1, and maintained phosphorylated when cells were cultured with IL-10. On IL-10 pulse, however, STAT3 phosphorylation declined rapidly in cells expressing IL10R1-G330R but not IL10R1-WT or S138G. Similar dynamics were observed with STAT1 phosphorylation at Tyr701. No differences in janus kinase 1 (JAK1) activation were observed in cells with WT or variant IL10R1. Our results indicate that IL10R1-G330R does not alter surface expression but duration of STAT phosphorylation, indicating that the position of G330 is important in stabilizing the STAT signal.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21654841      PMCID: PMC3173877          DOI: 10.1038/gene.2011.12

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  30 in total

Review 1.  The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29.

Authors:  Scott Commins; John W Steinke; Larry Borish
Journal:  J Allergy Clin Immunol       Date:  2008-04-11       Impact factor: 10.793

2.  Proteasome-mediated proteolysis of the interleukin-10 receptor is important for signal downregulation.

Authors:  Sherry H-Y Wei; Andrew Ming-Lum; Ying Liu; David Wallach; Christopher J Ong; Stephen W Chung; Kevin W Moore; Alice L-F Mui
Journal:  J Interferon Cytokine Res       Date:  2006-05       Impact factor: 2.607

3.  Relationship between diurnal rhythm of cell cycle and interferon receptor expression in implanted-tumor cells.

Authors:  H Takane; S Ohdo; T Yamada; S Koyanagi; E Yukawa; S Higuchi
Journal:  Life Sci       Date:  2001-02-09       Impact factor: 5.037

4.  Cell cycle-dependent expression of estrogen receptor and effect of estrogen on proliferation of synchronized human osteoblast-like osteosarcoma cells.

Authors:  A Ikegami; S Inoue; T Hosoi; M Kaneki; Y Mizuno; Y Akedo; Y Ouchi; H Orimo
Journal:  Endocrinology       Date:  1994-08       Impact factor: 4.736

5.  IL10R1 loss-of-function alleles in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  J Hermann; S Gruber; J B Neufeld; P Grundtner; M Graninger; W B Graninger; A Berghold; C Gasche
Journal:  Clin Exp Rheumatol       Date:  2009 Jul-Aug       Impact factor: 4.473

6.  Inflammatory bowel disease and mutations affecting the interleukin-10 receptor.

Authors:  Erik-Oliver Glocker; Daniel Kotlarz; Kaan Boztug; E Michael Gertz; Alejandro A Schäffer; Fatih Noyan; Mario Perro; Jana Diestelhorst; Anna Allroth; Dhaarini Murugan; Nadine Hätscher; Dietmar Pfeifer; Karl-Walter Sykora; Martin Sauer; Hans Kreipe; Martin Lacher; Rainer Nustede; Cristina Woellner; Ulrich Baumann; Ulrich Salzer; Sibylle Koletzko; Neil Shah; Anthony W Segal; Axel Sauerbrey; Stephan Buderus; Scott B Snapper; Bodo Grimbacher; Christoph Klein
Journal:  N Engl J Med       Date:  2009-11-04       Impact factor: 91.245

7.  Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex.

Authors:  Atsushi Matsuzawa; Ping-Hui Tseng; Sivakumar Vallabhapurapu; Jun-Li Luo; Weizhou Zhang; Haopeng Wang; Dario A A Vignali; Ewen Gallagher; Michael Karin
Journal:  Science       Date:  2008-07-17       Impact factor: 47.728

8.  Circulating neutrophils of septic patients constitutively express IL-10R1 and are promptly responsive to IL-10.

Authors:  Nicola Tamassia; Federica Calzetti; Nicola Menestrina; Marzia Rossato; Flavia Bazzoni; Leonardo Gottin; Marco A Cassatella
Journal:  Int Immunol       Date:  2008-02-27       Impact factor: 4.823

9.  The IL-10R1 S138G loss-of-function allele and ulcerative colitis.

Authors:  P Grundtner; S Gruber; S S Murray; S Vermeire; P Rutgeerts; T Decker; P L Lakatos; C Gasche
Journal:  Genes Immun       Date:  2008-09-18       Impact factor: 2.676

10.  Differential signaling of cmvIL-10 through common variants of the IL-10 receptor 1.

Authors:  Sabine G Gruber; Maria Gloria Luciani; Paul Grundtner; Alexander Zdanov; Christoph Gasche
Journal:  Eur J Immunol       Date:  2008-12       Impact factor: 6.688

View more
  4 in total

Review 1.  Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans.

Authors:  Dror S Shouval; Jodie Ouahed; Amlan Biswas; Jeremy A Goettel; Bruce H Horwitz; Christoph Klein; Aleixo M Muise; Scott B Snapper
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

2.  Interleukin-10 receptor-1 expression in monocyte-derived antigen-presenting cell populations: dendritic cells partially escape from IL-10's inhibitory mechanisms.

Authors:  S von Haehling; S H von Lanzenauer; K Wolk; C Höflich; S Kunz; B H Grünberg; W-D Döcke; U Reineke; K Asadullah; W Sterry; H-D Volk; R Sabat
Journal:  Genes Immun       Date:  2014-12-04       Impact factor: 2.676

3.  Evaluation of hepatitis C virus as a risk factor for HIV-associated neuroretinal disorder.

Authors:  Andrea D Branch; Lea T Drye; Mark L Van Natta; Efe Sezgin; Sarah L Fishman; Douglas T Dieterich; Curtis L Meinert; Douglas A Jabs
Journal:  Clin Infect Dis       Date:  2013-09-30       Impact factor: 9.079

4.  Novel missense mutation in the NOD2 gene in a patient with early onset ulcerative colitis: causal or chance association?

Authors:  Martina Girardelli; Josef Vuch; Alberto Tommasini; Sergio Crovella; Anna Monica Bianco
Journal:  Int J Mol Sci       Date:  2014-03-03       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.